Pfizer
Pfizer to acquire skin specialist firm Excaliard
November 28, 2011Sales and Marketing EXC 001, Excaliard, Pfizer
Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …
Pfizer’s Loughbeg first pharma facility to meet green standard
November 27, 2011Manufacturing and Production ISO 50001, Loughbeg, Pfizer, environmental
A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …
NICE okays Eliquis for blood clots after surgery
November 25, 2011Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer
NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …
Pfizer hatches mail order plan for Lipitor
November 23, 2011Sales and Marketing Lipitor, Pfizer, US, generics
Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
EMA accepts submission of Pfizer’s new arthritis drug
November 21, 2011Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib
The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …
Eliquis fails in head-to-head study against Lovenox
November 14, 2011Research and Development, Sales and Marketing BMS, Eliquis, Lovenox, Pfizer
Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …
Pfizer to retain an extra 300 jobs at Sandwich site
November 8, 2011Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich
Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma
November 7, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D
Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Ranbaxy to collaborate with Teva on generic Lipitor in US?
November 7, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
GSK, Pfizer joint venture to start manufacturing ops in Russia
November 4, 2011Manufacturing and Production GSK, Pfizer, manufacturing
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
Sanofi to become world’s biggest drug maker
November 2, 2011Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10
Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts. Pfizer’s nine-year …
Prevnar and Lyrica lift Pfizer results
November 1, 2011Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry
Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter. …
Pfizer to research prescription drug costs for the elderly
October 14, 2011Sales and Marketing Pfizer
Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …
Pfizer taps into Saudi stimulus package with new plant
October 10, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has unveiled expansion plans for the Middle East region with an agreement to open a manufacturing plant in Saudi …
Pfizer to cut 11% of its workforce in Spain
September 22, 2011Sales and Marketing Pfizer, Spain, job cuts
Pfizer will cut 220 jobs in Spain as the government reduces spending on pharmaceuticals to help offset its growing debt …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
